Literature DB >> 2069415

Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients.

J Solá1, L Vila, L Puig, J M de Moragas.   

Abstract

We evaluated the metabolism of exogenous arachidonic acid in polymorphonuclear leukocytes from psoriatic patients in comparison with those from normal subjects. The leukocytes were incubated with 10 microM labelled arachidonic acid and 5 microM A23187 for varying periods of time. We evaluated all the compounds derived from the 5-lipoxygenase activity, including the products of non-enzymatic transformation of leukotriene A4 and w-oxidized leukotriene B4. In the experimental conditions used, there was no significant difference in the formation of any compound at any time of incubation. These results indicate that there is no intrinsic alteration either in 5-lipoxygenase activity or in w-oxidation ability of circulating polymorphonuclear leukocytes in psoriatic patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069415     DOI: 10.1007/BF00371612

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

1.  Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin.

Authors:  E A Duell; C N Ellis; J J Voorhees
Journal:  J Invest Dermatol       Date:  1988-11       Impact factor: 8.551

2.  The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis.

Authors:  P D Maurice; R D Camp; B R Allen
Journal:  Prostaglandins       Date:  1987-06

3.  Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasis.

Authors:  T Ruzicka; H Radspieler; T Strasser; B Przybilla; J Ring
Journal:  Prostaglandins Leukot Med       Date:  1985-06

4.  In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.

Authors:  K Kragballe; L Desjarlais; E A Duell; J J Voorhees
Journal:  J Invest Dermatol       Date:  1986-07       Impact factor: 8.551

5.  Arachidonic acid metabolism by peripheral blood cells in psoriasis.

Authors:  P D Maurice; B R Allen; S Heptinstall; P C Bather
Journal:  Br J Dermatol       Date:  1986-05       Impact factor: 9.302

6.  Metabolism of [14C]arachidonic acid by polymorphonuclear leukocytes in patients with psoriasis.

Authors:  M Stüning; U Schultz-Ehrenburg; P Altmeyer; M Raulf; W König
Journal:  Br J Dermatol       Date:  1987-02       Impact factor: 9.302

7.  Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.

Authors:  T Ruzicka; T Simmet; B A Peskar; J Ring
Journal:  J Invest Dermatol       Date:  1986-02       Impact factor: 8.551

8.  Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes.

Authors:  W S Powell
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

9.  Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.

Authors:  S Hammarström; M Hamberg; B Samuelsson; E A Duell; M Stawiski; J J Voorhees
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

10.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

View more
  1 in total

1.  Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.

Authors:  Antonio Brú; Juan-Carlos Souto; Sonia Alcolea; Rosa Antón; Angel Remacha; Mercedes Camacho; Marta Soler; Isabel Brú; Amelia Porres; Luis Vila
Journal:  Mediators Inflamm       Date:  2010-02-11       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.